Abstract P2-24-03: Z-Endoxifen Allosterically Inhibits PKCβI and its Paradoxical Membrane Translocation
Sayantani Sarkar Bhattacharya(Indian Institute of Chemical Biology), Matthew J. Schellenberg(Mayo Clinic), Taylor L. Witter(Mayo Clinic), Anh Cong(Mayo Clinic in Arizona), John R. Hawse(Mayo Clinic in Arizona), Swaathi Jayaraman(Johns Hopkins University), Elizabeth S. Bruinsma(Mayo Clinic in Arizona), Matthew P. Goetz(Mayo Clinic)
Cited by 1
Related Papers
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|1.6k
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
|New England Journal of Medicine|2018|684
MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer
|npj Breast Cancer|2019|673
NCCN Guidelines Insights: Breast Cancer, Version 1.2017
|Journal of the National Comprehensive Cancer Network|2017|544